103 related articles for article (PubMed ID: 21596805)
1. Isolated diffusion restriction precedes the development of enhancing tumor in a subset of patients with glioblastoma.
Gupta A; Young RJ; Karimi S; Sood S; Zhang Z; Mo Q; Gutin PH; Holodny AI; Lassman AB
AJNR Am J Neuroradiol; 2011 Aug; 32(7):1301-1306. PubMed ID: 21596805
[TBL] [Abstract][Full Text] [Related]
2. A change in the apparent diffusion coefficient after treatment with bevacizumab is associated with decreased survival in patients with recurrent glioblastoma multiforme.
Paldino MJ; Desjardins A; Friedman HS; Vredenburgh JJ; Barboriak DP
Br J Radiol; 2012 Apr; 85(1012):382-9. PubMed ID: 21224297
[TBL] [Abstract][Full Text] [Related]
3. Differential gene expression in glioblastoma defined by ADC histogram analysis: relationship to extracellular matrix molecules and survival.
Pope WB; Mirsadraei L; Lai A; Eskin A; Qiao J; Kim HJ; Ellingson B; Nghiemphu PL; Kharbanda S; Soriano RH; Nelson SF; Yong W; Phillips HS; Cloughesy TF
AJNR Am J Neuroradiol; 2012 Jun; 33(6):1059-64. PubMed ID: 22268080
[TBL] [Abstract][Full Text] [Related]
4. Restriction Spectrum Imaging Improves Risk Stratification in Patients with Glioblastoma.
Krishnan AP; Karunamuni R; Leyden KM; Seibert TM; Delfanti RL; Kuperman JM; Bartsch H; Elbe P; Srikant A; Dale AM; Kesari S; Piccioni DE; Hattangadi-Gluth JA; Farid N; McDonald CR; White NS
AJNR Am J Neuroradiol; 2017 May; 38(5):882-889. PubMed ID: 28279985
[TBL] [Abstract][Full Text] [Related]
5. Radio-pathomic maps of glioblastoma identify phenotypes of non-enhancing tumor infiltration associated with bevacizumab treatment response.
Bobholz SA; Hoefs A; Hamburger J; Lowman AK; Winiarz A; Duenweg SR; Kyereme F; Connelly J; Coss D; Krucoff M; Banerjee A; LaViolette PS
J Neurooncol; 2024 Apr; 167(2):233-241. PubMed ID: 38372901
[TBL] [Abstract][Full Text] [Related]
6. Correction to: Radio-pathomic maps of glioblastoma identify phenotypes of non-enhancing tumor infiltration associated with bevacizumab treatment response.
Bobholz SA; Hoefs A; Hamburger J; Lowman AK; Winiarz A; Duenweg SR; Kyereme F; Connelly J; Coss D; Krucoff M; Banerjee A; LaViolette PS
J Neurooncol; 2024 Apr; 167(2):243. PubMed ID: 38498261
[No Abstract] [Full Text] [Related]
7. Longitudinal Evaluation of DCE-MRI as an Early Indicator of Progression after Standard Therapy in Glioblastoma.
Arevalo-Perez J; Trang A; Yllera-Contreras E; Yildirim O; Saha A; Young R; Lyo J; Peck KK; Holodny AI
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791921
[No Abstract] [Full Text] [Related]
8. Association of ADC of hyperintense lesions on FLAIR images with TERT promoter mutation status in glioblastoma IDH wild type.
Kamimura S; Mitobe Y; Nakamura K; Matsuda K; Kanemura Y; Kanoto M; Futakuchi M; Sonoda Y
Surg Neurol Int; 2024; 15():108. PubMed ID: 38628517
[TBL] [Abstract][Full Text] [Related]
9. The utility of arterial spin labeling imaging for predicting prognosis after a recurrence of high-grade glioma in patients under bevacizumab treatment.
Kambe A; Kitao S; Ochiai R; Hosoya T; Fujii S; Kurosaki M
J Neurooncol; 2024 Jan; 166(1):175-183. PubMed ID: 38165552
[TBL] [Abstract][Full Text] [Related]
10. Relationship between apparent diffusion coefficient and survival as a function of distance from gross tumor volume on radiation planning MRI in newly diagnosed glioblastoma.
Jabehdar Maralani P; Stewart J; Hiremath S; Lawrence L; Chan R; Lau A; Chen H; Chan A; Zeng LK; Tseng CL; Myrehaug S; Soliman H; Detsky J; Heyn C; Lim Fat M; Lipsman N; Sahgal A
J Neurooncol; 2023 Sep; 164(3):597-605. PubMed ID: 37707752
[TBL] [Abstract][Full Text] [Related]
11. Conventional and Advanced Imaging Techniques in Post-treatment Glioma Imaging.
Li AY; Iv M
Front Radiol; 2022; 2():883293. PubMed ID: 37492665
[TBL] [Abstract][Full Text] [Related]
12. FLAIRectomy: Resecting beyond the Contrast Margin for Glioblastoma.
Haddad AF; Young JS; Morshed RA; Berger MS
Brain Sci; 2022 Apr; 12(5):. PubMed ID: 35624931
[TBL] [Abstract][Full Text] [Related]
13. The potential of advanced MR techniques for precision radiotherapy of glioblastoma.
Tang PLY; Méndez Romero A; Jaspers JPM; Warnert EAH
MAGMA; 2022 Feb; 35(1):127-143. PubMed ID: 35129718
[TBL] [Abstract][Full Text] [Related]
14. Preoperative Apparent Diffusion Coefficient of Peritumoral Lesion Associate with Recurrence in Patients with Glioblastoma.
Matsuda K; Kokubo Y; Kanemura Y; Kanoto M; Sonoda Y
Neurol Med Chir (Tokyo); 2022 Jan; 62(1):28-34. PubMed ID: 34707068
[TBL] [Abstract][Full Text] [Related]
15. Imaging characteristics of H3 K27M histone-mutant diffuse midline glioma in teenagers and adults.
Thust S; Micallef C; Okuchi S; Brandner S; Kumar A; Mankad K; Wastling S; Mancini L; Jäger HR; Shankar A
Quant Imaging Med Surg; 2021 Jan; 11(1):43-56. PubMed ID: 33392010
[TBL] [Abstract][Full Text] [Related]
16. Stroke Mimics and Chameleons from the Radiological Viewpoint of Glioma Diagnosis.
Sasagawa A; Mikami T; Kimura Y; Akiyama Y; Sugita S; Hasegawa T; Wanibuchi M; Mikuni N
Neurol Med Chir (Tokyo); 2021 Feb; 61(2):134-143. PubMed ID: 33390559
[TBL] [Abstract][Full Text] [Related]
17. Emerging MRI Techniques to Redefine Treatment Response in Patients With Glioblastoma.
Gonçalves FG; Chawla S; Mohan S
J Magn Reson Imaging; 2020 Oct; 52(4):978-997. PubMed ID: 32190946
[TBL] [Abstract][Full Text] [Related]
18. Regorafenib CSF Penetration, Efficacy, and MRI Patterns in Recurrent Malignant Glioma Patients.
Zeiner PS; Kinzig M; Divé I; Maurer GD; Filipski K; Harter PN; Senft C; Bähr O; Hattingen E; Steinbach JP; Sörgel F; Voss M; Steidl E; Ronellenfitsch MW
J Clin Med; 2019 Nov; 8(12):. PubMed ID: 31766326
[TBL] [Abstract][Full Text] [Related]
19. Non-Contrast-Enhancing Tumor: A New Frontier in Glioblastoma Research.
Lasocki A; Gaillard F
AJNR Am J Neuroradiol; 2019 May; 40(5):758-765. PubMed ID: 30948373
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of glioblastoma with gliomatosis cerebri growth pattern on diffusion and perfusion MRI.
Förster A; Brehmer S; Seiz-Rosenhagen M; Mildenberger I; Giordano FA; Wenz H; Reuss D; Hänggi D; Groden C
J Neurooncol; 2019 Mar; 142(1):103-109. PubMed ID: 30565029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
